Microvessel density in pituitary adenomas and carcinomas

Virchows Archiv

Volumn 438, Issue 6, 2001, Pages 595-602

  Vidal, Sergio ^a,b   Kovacs, Kalman ^b   Horvath, Eva ^b   Scheithauer, Bernd W ^c   Kuroki, Takao ^d   Lloyd, Ricardo V ^c  

^a Campus Universitario de Lugo ^*  (Spain)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c MAYO CLINIC   (United States)

^d TOHO UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Immunohistochemistry; Pathology; Pituitary adenoma; Pituitary carcinoma

Indexed keywords

CD34 ANTIGEN; DOPAMINE RECEPTOR STIMULATING AGENT; KI 67 ANTIGEN; SOMATOSTATIN;

ADULT; ANGIOGENESIS; ARTICLE; CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; ANTIGENS, NUCLEAR; BROMOCRIPTINE; CARCINOMA; CHILD; DOPAMINE AGONISTS; FEMALE; HORMONES; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; OCTREOTIDE; PITUITARY NEOPLASMS;

EID: 0034912507     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000373     Document Type: Article

References (57)

1. Prognostic relevance of microvessel density in colorectal tumours
2. Proliferative potential in pituitary adenomas: Measurement by monoclonal antibody MIB-1
3. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
4. The cytogenesis and pathogenesis of pituitary adenomas
5. Matrix metalloproteinases and their inhibitors in human pituitary tumors
6. Aggressive pituitary tumors
7. Microvessel density in prostate cancer: Prognostic and therapeutic utility
8. Cushing's syndrome from ectopic pituitary adenoma with peliosis: A histological, immunohistochemical, and ultrastructural study and review of the literature
9. Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995)
10. Tumour vasculature as a target for anticancer therapy
11. The biology of vascular endothelial growth factor
12. Vasculogenic mimicry and tumor angiogenesis
13. The role of angiogenesis in tumor growth
14. Angiogenesis in cancer, vascular, rheumatoid and other disease
15. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene
16. Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation
17. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
18. Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: A quantitative morphologic study
19. Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas
20. Tumor angiogenesis: Past, present and the near future
21. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma
22. Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization
23. Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization
24. The World Health Organization classification of adenohypophysial neoplasms. A proposed five-tier scheme
25. Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line HECa10) culture
26. Vascular endothelial growth factor (VEGF) expression in human pituitary adenoma and carcinoma
27. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma
28. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry
29. Angiogenesis in breast cancer is related to age but not to other prognostic parameters
30. Markers of function and proliferation in non-invasive and invasive bi- and plurihormonal adenomas of patients with acromegaly: An immunohistochemical study
31. An immunohistochemical analysis of angiogenesis in invasive breast cancer with correlations to clinicopathologic predictors
32. Microvessels that predict axillary lymph node metastases in patients with breast cancer
33. High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells
34. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways
35. Pituitary carcinoma: A clinicopathologic study of 15 cases
36. Oncogenes and tumor angiogenesis: Differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts
37. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha
38. Angiogenesis: How a tumor adapts to hypoxia
39. Clonal composition of pituitary adenomas in patients with Cushing's disease: Determination by X-chromosome inactivation analysis
40. Genetic basis of endocrine disease: Pituitary tumor pathogenesis
41. Comparison of different immunohistochemical methods in the assessment of angiogenesis: Lack of prognostic value in a group of 77 selected node-negative breast carcinomas
42. Effect of dopamine agonists on lactotroph adenomas of the human pituitary
43. The prognostic significance of tumor vascularization in patients with localized colorectal cancer
44. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody
45. p53 expression in pituitary adenomas and carcinomas: Correlation with invasiveness and tumor growth fractions
46. Intratumoral neovascularization and growth pattern in early gastric carcinoma
47. Angiogenesis in pituitary adenomas - Relationship to endocrine function, treatment and outcome
48. Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: Relationship to tumour behaviour
49. Angiogenesis in pituitary adenomas and the normal pituitary gland
50. Simultaneous localization of Pit-1 protein and gonadotropins on the same cell type in the anterior pituitary glands of the rat
51. Expression of Von Hippel-Lindau (VHL-P) in nontumorous and adenomatous human pituitaries
52. Vascularity in non-tumorous human pituitaries and incidental microadenomas. A morphometric study
53. Clonal analysis using recombinant DNA probes from the X-chromosome
54. Tumor angiogenesis: Review of current applications in tumor prognostication
55. Tumour vascularity and proliferation: Clear evidence of a close relationship
56. Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis
57. Expression of P27kip1 and Ki-67 in pituitary adenomas: An investigation of marker of adenoma invasiveness